Paratek Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics based upon tetracycline chemistry, has executed an amended lease agreement for additional office space in Boston
The amended lease agreement adds 4,153 rentable square feet of office space, for a commitment of $1.1 million, and extends its original lease term by two years, for an additional commitment of $0.9 million.
The company lists its headquarters as 75 Park Plaza, located in Boston’s Back Bay, where it previously occupied 8,000 square feet of office space under a lease that expired in 2019. The company’s original Boston headquarters lease signed in April 2015 was for four years with one renewal option for an extended term. The lease term began in July 2015.
75 Park Plaza is a 12-story, 502,000 square foot multi-use project with office space on the second, third and fourth floors, according to LoopNet. The Class A building was developed in 1988.